Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Price to Earnings (2014 - 2026)

Analysis

Eledon Pharmaceuticals (ELDN) Price to Earnings (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.15
Mar 31, 2026 -16.35
Sep 30, 2025 -10.48
Jun 30, 2025 -18.64
Mar 31, 2025 -43.58
Dec 31, 2024 -6.10
Sep 30, 2024 24.25
Jun 30, 2024 -8.76
Mar 31, 2024 -3.28
Dec 31, 2023 -5.27
Sep 30, 2023 -4.58
Jun 30, 2023 -3.81
Mar 31, 2023 -5.26
Dec 31, 2022 -0.96
Sep 30, 2022 -6.53
Jun 30, 2022 -6.53
Mar 31, 2022 -6.87
Dec 31, 2021 -21.82
Sep 30, 2021 -11.26
Jun 30, 2021 -19.16